scholarly journals Evaluating of the effectiveness and safety of the reproduced selective beta1-blocker without intrinsic sympathomimetic activity Bidop in patients with hypertrophic cardiomyopathy

2016 ◽  
Vol 13 (2) ◽  
Author(s):  
L.I. Feiskhanova ◽  
A.A. Malov
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Intrinsic Sympathomimetic Activity

scholarly journals Evaluating of the effectiveness and safety of the reproduced selective β1-blocker without intrinsic sympathomimetic activity Bidop® in patients with hypertrophic cardiomyopathy

2016 ◽  
Vol 13 (2) ◽  
pp. 88-90
Author(s):  
L I Feiskhanova ◽  
A A Malov
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Left Ventricle ◽  
Diastolic Function ◽  
Interventricular Septum ◽  
Outflow Tract ◽  
Intrinsic Sympathomimetic Activity ◽  
Active Relaxation

The article assesses the effectiveness of therapy generics Bidop® production of Gedeon Richter (Hungary), designated to improve diastolic function, and treatment of heart failureof patients with hypertrophic cardiomyopathy with predominant hypertrophy of the interventricular septum and symmetrical concentric shape in the absence of obstruction of outflow tract of the left ventricle (LV). The effect of the presence of zones of intramyocardial fibrosis hypertrophied LV departments identified through MRI delayed contrast, to the process of active relaxation.

636 Discrepancy between endocardial and midwall mechanics in hypertrophic cardiomyopathy

1999 ◽  
Vol 1 ◽  
pp. S107-S107
Author(s):  
S SEVERINO ◽  
P CASO ◽  
M GALDERISI ◽  
S CICALA ◽  
A DANDREA ◽  
...  
Keyword(s):  
Hypertrophic Cardiomyopathy
Sign in / Sign up

Export Citation Format

Share Document